The panelist discusses how for managing patients with R/R multiple myeloma, community clinicians should focus on personalized ...
Sanofi has received China’s National Medical Products Administration (NMPA) approval for the use of Sarclisa (isatuximab), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback